94 related articles for article (PubMed ID: 17003348)
41. Uncoupling by (--)-epigallocatechin-3-gallate of ATP-sensitive potassium channels from phosphatidylinositol polyphosphates and ATP.
Jin JY; Park SH; Bae JH; Cho HC; Lim JG; Park WS; Han J; Lee JH; Song DK
Pharmacol Res; 2007 Sep; 56(3):237-47. PubMed ID: 17656102
[TBL] [Abstract][Full Text] [Related]
42. Pharmacogenomic analysis of ATP-sensitive potassium channels coexpressing the common type 2 diabetes risk variants E23K and S1369A.
Lang VY; Fatehi M; Light PE
Pharmacogenet Genomics; 2012 Mar; 22(3):206-14. PubMed ID: 22209866
[TBL] [Abstract][Full Text] [Related]
43. Does inhibiting Sur1 complement rt-PA in cerebral ischemia?
Simard JM; Geng Z; Silver FL; Sheth KN; Kimberly WT; Stern BJ; Colucci M; Gerzanich V
Ann N Y Acad Sci; 2012 Sep; 1268():95-107. PubMed ID: 22994227
[TBL] [Abstract][Full Text] [Related]
44. Granule mobility, fusion frequency and insulin secretion are differentially affected by insulinotropic stimuli.
Schumacher K; Matz M; Brüning D; Baumann K; Rustenbeck I
Traffic; 2015 May; 16(5):493-509. PubMed ID: 25615411
[TBL] [Abstract][Full Text] [Related]
45. The antidiabetic drug glibenclamide exerts direct retinal neuroprotection.
Berdugo M; Delaunay K; Naud MC; Guegan J; Moulin A; Savoldelli M; Picard E; Radet L; Jonet L; Djerada Z; Gozalo C; Daruich A; Beltrand J; Jeanny JC; Kermorvant-Duchemin E; Crisanti P; Polak M; Behar-Cohen F
Transl Res; 2021 Mar; 229():83-99. PubMed ID: 33080394
[TBL] [Abstract][Full Text] [Related]
46. Hetero-bivalent GLP-1/glibenclamide for targeting pancreatic β-cells.
Hart NJ; Chung WJ; Weber C; Ananthakrishnan K; Anderson M; Patek R; Zhang Z; Limesand SW; Vagner J; Lynch RM
Chembiochem; 2014 Jan; 15(1):135-45. PubMed ID: 24259278
[TBL] [Abstract][Full Text] [Related]
47. Mechanism of Action of Novel Glibenclamide Derivatives on Potassium and Calcium Channels for Insulin Secretion.
Frederico MJS; Castro AJG; Menegaz D; Murat CB; Mendes CP; Mascarello A; Nunes RJ; Silva FRMB
Curr Drug Targets; 2017; 18(6):641-650. PubMed ID: 27316908
[TBL] [Abstract][Full Text] [Related]
48. A Ratiometric Sensor for Imaging Insulin Secretion in Single β Cells.
Schifferer M; Yushchenko DA; Stein F; Bolbat A; Schultz C
Cell Chem Biol; 2017 Apr; 24(4):525-531.e4. PubMed ID: 28366620
[TBL] [Abstract][Full Text] [Related]
49. Imaging Insulin Granule Dynamics in Human Pancreatic β-Cells Using Total Internal Reflection Fluorescence (TIRF) Microscopy.
Kang F; Gaisano HY
Methods Mol Biol; 2022; 2473():79-88. PubMed ID: 35819760
[TBL] [Abstract][Full Text] [Related]
50. β-Cell-intrinsic β-arrestin 1 signaling enhances sulfonylurea-induced insulin secretion.
Barella LF; Rossi M; Zhu L; Cui Y; Mei FC; Cheng X; Chen W; Gurevich VV; Wess J
J Clin Invest; 2019 Jun; 129(9):3732-3737. PubMed ID: 31184597
[TBL] [Abstract][Full Text] [Related]
51. The TRPA1 channel and oral hypoglycemic agents: is there complicity in β-cell exhaustion?
Diaz-Garcia CM
Channels (Austin); 2013; 7(6):420-2. PubMed ID: 23921548
[TBL] [Abstract][Full Text] [Related]
52. Mitiglinide: KAD 1229, S 21403.
Drugs R D; 2004; 5(2):98-101. PubMed ID: 15293870
[TBL] [Abstract][Full Text] [Related]
53. Design, Synthesis, Molecular Modeling and Anti-Hyperglycemic Evaluation of Quinazoline-Sulfonylurea Hybrids as Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) and Sulfonylurea Receptor (SUR) Agonists.
El-Zahabi MA; Bamanie FH; Ghareeb S; Alshaeri HK; Alasmari MM; Moustafa M; Al-Marzooki Z; Zayed MF
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077003
[TBL] [Abstract][Full Text] [Related]
54. Efforts to develop methods for in vivo evaluation of the native beta-cell mass.
Schneider S
Diabetes Obes Metab; 2008 Nov; 10 Suppl 4():109-18. PubMed ID: 18834438
[TBL] [Abstract][Full Text] [Related]
55. Structural Insights Into the High Selectivity of the Anti-Diabetic Drug Mitiglinide.
Wang M; Wu JX; Chen L
Front Pharmacol; 2022; 13():929684. PubMed ID: 35847046
[TBL] [Abstract][Full Text] [Related]
56. Diabetes, Obesity, COVID-19, Insulin, and Other Antidiabetes Drugs.
Dandona P; Ghanim H
Diabetes Care; 2021 Sep; 44(9):1929-1933. PubMed ID: 34244331
[No Abstract] [Full Text] [Related]
57. Dairy of a newcomer.
SCHWALM VI
Am J Nurs; 1960 Apr; 60():530-3. PubMed ID: 14443946
[No Abstract] [Full Text] [Related]
58. Taking a history with newcomer children and adolescents.
Vo D
Paediatr Child Health; 2014 Feb; 19(2):87-8. PubMed ID: 24596482
[No Abstract] [Full Text] [Related]
59. Noncanonical Regulation of cAMP-Dependent Insulin Secretion and Its Implications in Type 2 Diabetes.
Ramanadham S; Turk J; Bhatnagar S
Compr Physiol; 2023 Jun; 13(3):5023-5049. PubMed ID: 37358504
[TBL] [Abstract][Full Text] [Related]
60. The changing view of insulin granule mobility: From conveyor belt to signaling hub.
Gaus B; Brüning D; Groß S; Müller M; Rustenbeck I
Front Endocrinol (Lausanne); 2022; 13():983152. PubMed ID: 36120467
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
